September 14, 2022 — GE Healthcare and Lantheus Holdings Inc have announced that the recent Phase III clinical trial of ...
September 14, 2022 — In recognition of Atrial Fibrillation (AFib) Awareness Month, Biosense Webster, Inc., part of ...
September 13, 2022 — Anthos Therapeutics, a clinical-stage biotechnology company developing innovative therapies for ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
September 13, 2022 — The latest expert consensus document from the Society of Cardiovascular Computed Tomography (SCCT) ...
September 13, 2022 — The ŌNŌ endovascular retrieval system was recently used to remove a malpositioned leadless ...
September 13, 2022 — ZOLL Medical Corporation, an Asahi Kasei company that manufactures medical devices and related ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
The Transcatheter Cardiovascular Therapeutics (TCT) conference, which is the Cardiovascular Research Foundation's (CRF) ...
September 12, 2022 — Boston Scientific Corporation has received U.S. Food and Drug Administration (FDA) approval to ...
September 12, 2022 — Researchers at the National Institutes of Health have found that a novel blood test can be used to ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
September 12, 2022 — Royal Philips, a global leader in health technology, announced new milestones in the development of ...
September 9, 2022 — The U.S. Food and Drug Administration (FDA) is alerting healthcare providers about potential clip ...
September 9, 2 022 — A large-scale international study led by Mount Sinai has yielded the first risk score that can help ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
September 9, 2022 — The probability of surviving sudden cardiac arrest outside hospital has more than doubled in 30 ...
September 8, 2022 — A clinical trial led by investigators from Brigham and Women’s Hospital has found that the long-term ...
September 8, 2022 — PrepMD RMS, the premier cardiac clinical solutions company, announced today the acquisition of the ...